anthony fauci director national institute allergy infectious disease bethesda maryland vaccine co developer fauci says told reporters months ago satisfied vaccine 70 75 effective prevented 95 cases aspirational aspirations met good news adds moderna developers announce working covid-19 vaccine testing clinical trials humans vaccine comprised rna instructions cells produce modified form coronavirus spike protein immune system key target coronaviruses began phase iii trial enrolled roughly 30,000 people 27 july trial continues analysis conducted 15 november independent data safety committee found 95 participants trial developed covid-19 90 group received placebo injection 5 received vaccine equates efficacy 94.5 pfizer biontech reported greater